Back to Top

Information For Authors

Please be sure to visit the Journal’s Policies Page.  

Visit the Journal’s statement on Standards and Best Practices  

All manuscripts must be submitted through our online peer review system.    Please read all instructions before submitting.

Palliative Medicine Reports (PMR) is the open access companion journal to the Journal of Palliative Medicine.  PMR publishes peer-reviewed articles covering medical, psychosocial, policy, and legal issues in end-of-life care. PMR will also widely consider a variety of front matter material that will be available to both clinical and lay audiences and will present essential information for professionals in hospice and palliative medicine, focusing on improving quality of life for patients and their families, and the latest developments in drug and non-drug treatments. From caregiver and palliative care nursing concerns and considerations, to educational design, PMR will be the go-to open access resource for family members of palliative patients, palliative and hospice clinicians and nurses, and palliative patients around the globe.

Article Publication Charges (APCs)

Palliative Medicine Reports is a fully Open Access journal. The Article Processing Charge (APC) is $1250.00 USD.


Click here for the Journal’s statement on Open Access and Funding Information including Research funder compliance (FundRef); Government funded research; NIH/HHMI/WellcomeTrust; and RCUK compliance.

Click here for the Journal’s Peer Review Policies on Confidentiality in peer review; Sharing of materials during peer review; Papers authored by the Editor-in-Chief and/or Associate Editors; Self-citation and self-plagiarism; and Average time in review.

All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

CREATE AN ACCOUNT IN MANUSCRIPT CENTRAL SPECIFICALLY FOR Palliative Medicine Reports

Click here to submit your paper to our online peer review system Please read all instructions before submitting.


If you do not already have a separate account in Manuscript Central for Palliative Medicine Reports, you will need to create one.  Once your account is created, you may log in to the system to begin your submission.

Follow all prompts on Manuscript Central for inputting all required manuscript details. Please upload all files pertaining to your paper individually; do NOT combine all manuscript files into one PDF for uploading. Manuscript Central prepares a PDF proof after uploading is completed.

Please see Required Content in Manuscript Submissions regarding author disclosures statements and IRB statements.

Click here for the Journal’s Study Design/Ethics Requirements/Approvals, such as Internal Review Board approvals/waivers; Ethics of experimentation; and Ethical treatment of animals

See Authorship Qualifications and Responsibilities for guidance on Determining authorship, Who qualifies as a non-author contributor; ORCID IDs; Authorship limit; Corresponding author; Working groups/Team authorship; Variations of authorship; Changes in authorship; Exclusivity; Use of the English language; Author disclosure statements; Self-citation and self-plagiarism; Author affiliations, and Reprints.

Article Types and Word Limits
Note:  Abstract, references, disclosure statements, acknowledgments, figure legends, tables, and appendices do NOT count towards stated word limits.

NOTE:  Supplemental Information, if provided, will not be copyedited or typeset; it will be posted online as supplied.)

Preparation of Original Submissions

Original manuscripts are generally reports of completed research studies and may not exceed 3,000 words. A structured abstract of 250 words or less using the following guidelines must be included and should be self-explanatory without reference to the text:

•    Background (Why was this report needed)
•    Objective (What did you set out to do?)
•    Design (How did you go about doing it)
•    Setting/Subjects (If this was a clinical trial, in what setting was it done and who were the subjects).  Please be sure to specifically identify the country of study in the Abstract, within the Settings/Subjects section.
•    Measurements
•    Results (What did you discover)
•    Conclusions

Number pages consecutively, including the title page.  A title page with information for all authors including full names, degrees, affiliations, and contact information should be included and uploaded separately. The main document should be a blind submission with no author names or affiliations. The manuscript file should also contain the abstract after the title page, and before the introduction.

Preparation of Brief Report

This category is for research that is less well developed than reported in an original manuscript and may not exceed 1,500 words. The results of preliminary studies, pilot programs, or small series on which an hypothesis can be formulated and tested in a subsequent study are good candidates for this category. Palliative Medicine Reports is particularly interested in fostering the careers of junior investigators, or those new to the field of palliative medicine research. Please include a structured abstract as for an original manuscript.

Preparation of a Brief Communication

Results of research or the development of ideas may be reported in a Brief Communication. Not more than 500 words, brief communications are often the richest source of new insights or serendipitous observations on which the future of the field may turn. This section is meant to transmit information that is much more ‘raw’ or ‘untested’ but holds promise in furthering the field through stimulating further research, discussion, or resolving controversy. Only one table OR one figure and no more than a total of four (4) references are permitted for the Brief Communications.

Preparation of an Editorial or Special Report

From time to time, an unsolicited report from an important group or meeting, or a description of a phenomenon in the field, or a particular point of view deserves publication. These decisions rest solely with the Editor-in-Chief.

Preparation of a Personal Reflection

One of the most widely read features in the journal, the personal reflections are written in a way that illustrates the personal engagement with the field—either its struggles or its joys or the complex combination of the two. Prose and poetry have all found a place here. Acceptance is at the sole discretion of the Managing Editor and Editor.

Preparation of a Letter to the Editor

Letters to the Editor provide a forum for readers to comment on articles published in recent issues of Palliative Medicine Reports. Text should be limited to 500, with one figure OR table, and with a maximum of four (4) references.

Preparation of Case Discussions

Types of cases:

Case Discussions in Palliative Medicine presents case-based examinations of topics relevant to the practice of palliative care. The Journal welcomes manuscripts that fit the traditional case report paradigm, e.g. a description of a rare diagnosis, unusual outcome, or new treatment modality. Reports of meaningful cases that do not necessarily report something “unusual,” but that would be of interest to a broad palliative care audience are also encouraged. We strongly encourage use of the existing evidence base. The main ‘outcome’ against which we will measure submissions is:

•    will a community physician or nurse practitioner be able to look at this, and
•    feel s/he has attended a worthwhile discussion, and
•    come away with one thing s/he might do differently in his/her practice?

In addition to traditional medical cases, The Journal welcomes cases illustrating issues that go beyond medical knowledge and patient care.   Using the six ACGME competencies* as an inspiration, we encourage submission of case discussions that address communication issues, ethics, professionalism, and systems-based practice.

Length: 2000 words or less (excluding abstract, references, acknowledgments, disclosures tables, figures)

Format:   Abstract;  Introduction;  Case Description;  Discussion;   References

A successful manuscript will meet the following criteria:

  • Material is original and has not been published elsewhere. (Cases previously presented as posters or abstracts may be accepted.)
  • Writing is clear and in accordance with the AMA Manual of Style, 10th edition.

All words should be spelled in American English.

*Six ACGME competencies:    Medical Knowledge;    Patient Care;  Interpersonal and Communication; Skills;    Professionalism;  Practice-based Learning and Improvement;   Systems-based Practice

Click here for definitions of the ACGME competencies.

Unless otherwise noted, Palliative Medicine Reports follows the Uniform Requirements for Manuscripts Submitted to Biomedical Journals. See: Uniform requirements for manuscripts submitted to biomedical journals. International Committee of Medical Journal Editors. Ann Intern Med. 1997;126:36–47.

Disclosure Statement
Immediately following the Acknowledgments section, include a section entitled “Author Disclosure Statement.” This text must be part of your actual manuscript file.
 
In this portion of the paper, authors must disclose any commercial associations that might create a conflict of interest in connection with submitted manuscripts. This statement should include appropriate information for EACH author, thereby representing that competing financial interests of all authors have been appropriately disclosed according to the policy of the Journal. It is important that all conflicts of interest, whether they are actual or potential, be disclosed. If no conflicts exist, the authors must state “No competing financial interests exist.”

This information will remain confidential while the paper is being reviewed and will not influence the editorial decision.

Click here to view the Uniform Requirements for Manuscripts Submitted to Biomedical Journals at http://www.icmje.org/index.html#conflicts for further guidance.

See Copyright, Licensing, Reuse, and Permissions as well as Data Sharing and Preprint Policies 

File Naming

  • Name all files in English and use only alphanumeric characters.  Do not use symbols, dots, lines, or dashes.
  • Figure files names should be formatted with first author’s last name and the figure number. (Ex:  SmithFig1)

Figures

  • Prepare each figure as individual .TIFF or .EPS file.
  • Do NOT submit figures in Word, PowerPoint, PDF, Bitmap, .JPEG, or Excel.
  • Line illustrations must be submitted at 900 DPI.
  • Halftones and color should be submitted at a minimum of 300 dpi.
  • Color art must be saved as CMYK - not RGB. (N.B., If RGB files are submitted, the files will be converted to CYMK and some color variation will occur.)
  • Black and white art must be submitted as grayscale – not RGB.

Additional Information on Converting Figure Files

Converting Word or Excel files: The best and easiest way to convert Word or Excel files into a format which is suitable for print is to scan them using the below guidelines:

  •  All files should be scanned at 100% size
  •  At least 300 dpi
  •  Final color mode: CMYK
  •  Save file as: .tif, .tiff, or .eps

Click here for more direction on converting a Power Point slide to an acceptable format.

Tables:

  • Prepare and save each table in individual .doc or .docx files.
  • Do not include tables in the main manuscript text file.
  • Do not embed tables within the text.
  • Include a table number and a title for each supplied table.
  • Use Arabic numerals to number tables.
  • Do not repeat information that is given in the text, and do not make a table for data that can be given in the text in one or two sentences.
  • Define all acronyms used within the body of the table in table footnotes.
  • All other types of table footnotes should be designated using superscript letters, not symbols.
  • Name all table files in English and use only alphanumeric characters.  Do not use symbols, dots, lines, or dashes.
  • Table file names should be formatted with first author’s last name and the table number. (Ex:  SmithTable1)
  • Upload individual table file under the “Table” file designation.

IMPORTANT:

Please upload individual files of all manuscript material - do NOT upload a single PDF file containing all text, figure, and table files of your article.  Once all individual files are uploaded on to Manuscript Central, the system will automatically create a single PDF proof for you and the peer-review process.
 
Abbreviations
Abbreviations of journal titles should follow MEDLINE.
 
References
References should be presented in numerical order and in the following style:

  • Journal articles: Christakis NA, Escarce JJ: Survival of medicare patients after enrollment in hospice programs. New Engl J Med 1996;335:172–178.
  • Chapter in a book: Lipman AG, Gauthier ME: Pharmacology of opioid analgesics: Basic problems.  In: Portenoy RK, Bruera E (eds): Topics in Palliative Care, Volume I.  New York: Oxford University Press, 1997, pp. 137–162.
  • Book: Oxford Textbook of Palliative Medicine, 3e. Doyle D, Hank G, Cherny N (eds). Oxford University Press, New York, NY, 2005.

For references containing more than four authors, list the first three, followed by et al.
 
If it is necessary to cite an abstract, this should be designated.
 
Authors are responsible for the accuracy of the reference, and are reminded that inaccurate references are highly frustrating to the reader, the cited author, and indexing services.

See Post-Acceptance and Post-Publication Policies regarding email communications, production, page proofs, reprints, post-publication corrections, and our policy on official retractions.

Click here for the Publisher’s Press Embargo Policy

Permissions
 
The author(s) must obtain permission to reproduce figures, tables and text from previously published material. Written permission must be obtained from  the  original  copyright  holder (generally the publisher, not the author or editor) of the journal or  book  concerned. An appropriate credit line should be included in the figure or legend or table footnote, as well as in the reference list. Written permission must be obtained from the author of any unpublished material cited from other sources, and should accompany the manuscript.

See our policy on Responding to Allegations of Scientific Misconduct

Click here for Publisher’s contact information.

 

All Mary Ann Liebert, Inc. journals follow the standards, guidelines, and best practices set forth by the -Committee on Publication Ethics (COPE; publicationethics.org), the International Committee of Journal Medical Editors (ICJME; www.icmje.org), the World Medical Association (WMA); www.wma.net) and the American Medical Association (www.ama-assn.org).

Palliative Medicine Reports is a double-blinded peer-reviewed journal. All submissions are subject to peer review. Upon submission, manuscripts are assessed by an editor for suitability for the journal.  For those that are deemed suitable, a minimum of two expert reviewers in the area of study will be selected to assess the scientific basis and significance of the manuscript. Following peer review, the Editor and/or Associate Editors will determine if the paper should be accepted, require revision, or is unacceptable for publication.

Confidentiality in Peer Review

Editors and reviewers must maintain strict confidentiality of manuscripts during the peer-review process. Sharing a manuscript in whole or in part, outside the scope of what is necessary for assessment, is impermissible prior to an accepted manuscript's official publication date.

Sharing of Materials during Peer Review

Authors must honor any reasonable request for materials, methods, or data necessary to reproduce or validate the research findings during peer review unless it violates the privacy or confidentiality of human research subjects.

Papers Authored by the Editor-in-Chief and/or Associate Editors

The Editor-in-Chief and Associate Editors will recuse themselves from participating in the review process of any manuscript in which there is a potential or actual competing interest.

Self-Citation and Self-Plagiarism

JPalliative Medicine Reports is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to peer review. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content (i.e., Materials and Methods) compared to work previously published by authors, self-plagiarism can infringe upon copyright. To avoid plagiarism, be sure to properly cite and reference all published works. (Deposition of a preprint on a preprint server is not considered as prior publication and will not impact consideration of any submitted manuscript.)

Time in Review

Palliative Medicine Reports aims to maintain a short, but thorough peer-review process. The average time in review is 30 days.  However, the Editor(s) will strive to expedite manuscript handling if/when special circumstances dictate.

ATTENTION:  To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.

AUTHORSHIP

Definition of Authorship

Authorship, as defined by the International Committee of Medical Journal Editors, is based on the following criteria:

  • Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND
  • Drafting the work or revising it critically for important intellectual content; AND
  • Final approval of the version to be published; AND
  • Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Non-Author Contributors

Contributors who meet fewer than all four of the above criteria for authorship should not be listed as authors, but they should be acknowledged in the Acknowledgments section with a description of their contribution to the work.

For further information, visit the International Committee of Medical Journal Editors’ website at: http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

ORCID IDs

All submitting authors are required to complete their submissions using an ORCID identifier. Please visit the ORCID website for more information, or to register.

AUTHORSHIP LIMIT

There is a limit of 35 of authors permitted on a single submission, but in cases where there are 20 or more co-authors, Palliative Medicine Reports recommends that a collective group or consortium name be provided and the individual authors listed in the Acknowledgements.

CORRESPONDING AUTHOR**

One author should be designated as the corresponding author who will be responsible for communication between the authors and the journal editorial office(s) and publisher. This individual will be responsible for ensuring all authors submit copyright forms and coordinating and responding to page proofs, as well as any managing any other necessary contact during the peer review and/or production processes.

**NOTE: Due to configuration restraints, the submission system permits only one author to be identified as the corresponding author of record. However, we recognize that some submissions call for more than one corresponding author to be noted. In such cases, select one author to be the main point of contact and/or corresponding author for all communications regarding the peer review process of the paper, but on the title page of the manuscript, designate additional co-corresponding authors by including an asterisk after the authors' names in the byline, and include an accompanying footnote on the title page that reads, "*Co-corresponding authors."  Please ensure that the title page of the submission page carries the full affiliation details and email addresses of all authors who should be noted as a corresponding author. If the paper is accepted for publication, the full contact information for all desginated co-authors will be listed at the end of the article as per usual journal style.

WORKING GROUPS / TEAM AUTHORSHIP

Working Groups or Teams may be listed in the manuscript byline, but the entire listing of names and affiliations should be included in the acknowledgment section of the manuscript. Do not list the names in a footnote on the title page.

VARIATIONS OF AUTHORSHIP

It is permissible to list up to three authors as co-first authors, or as contributing equally to the work. Include an asterisk (*) next to the authors' names who are considered as first authors. Include a corresponding footnote, using the asterisk, on the title page that reads, "These authors contributed equally to this work and are considered to be co-first authors."

CHANGES IN AUTHORSHIP

Changes in authorship after submission or acceptance of a paper are strongly discouraged, but the editorial leadership recognizes that in certain circumstances, it may be required. The journal's policy for such cases is as follows:

  • A request to alter authorship must be made in writing from the corresponding author to the Editor-in-Chief, with a detailed explanation for the request, and the names and affiliations of the authors requiring addition and/or deletion.
  • Authorship may be altered after submission or acceptance of a paper ONLY with the expressed written approval of all authors named on the manuscript, as well as the individual(s) being added and/or deleted. The Publisher can provide a form for this, if needed.
  • Upon receipt of the request and all written approvals of all involved parties, the Editor-in-Chief will consider the request, render a decision, and notify the corresponding author.
  • There is a one-year post-publication statute of limitation on requests for alterations in authorship.
  • Post-publication changes or alterations to conference abstracts are prohibited.

ATTENTION: To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.

EXCLUSIVITY

Manuscripts should be submitted with the understanding that they have neither been published, nor are under consideration for publication elsewhere, in the same form or substantially similar form, except in the form of a conference abstract.  If work was presented at a conference, supply the name, date, and location of the meeting as a footnote on the title page of the submission.

USE OF ENGLISH LANGUAGE

All submissions must be in English. Appropriate use of the English language is a requirement for review and publication in Palliative Medicine Reports. For authors whose native language is not English, we recommend using a service that will aid in the translation and rewriting of material into correct and proper English usage. The Publisher offers this service for a fee prior to official submission. For more information, please contact: Editing@liebertpub.com Please note that employing the use of the Publisher's service is not required and using it, or any other language editing service, does not guarantee acceptance of any paper. All submissions are subject to peer review.

AUTHOR DISCLOSURE STATEMENTS

  • Competing Interests. A competing interest exists when an individual (or the individual's institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
  • Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
  • Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
  • Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
  • Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.

SELF-CITATION AND SELF-PLAGIARISM

Palliative Medicine Reports is committed to maintaining the integrity of the peer review process by upholding the highest standards for all published articles. All manuscripts will be processed through plagiarism detection software prior to peer review. Plagiarized manuscripts will be rejected immediately. While a manuscript submission may contain some redundancy in language and content (i.e., Materials and Methods) compared to work previously published by authors, self-plagiarism can infringe upon copyright. To avoid plagiarism, be sure to properly cite and reference all published works.

AFFILIATIONS

Authors should identify as their institution(s) the facility where the work was performed and executed.  Changes in an author’s affiliation after the work was completed but prior to the submission or publication of the manuscript should be noted by including an asterisk as a superscript to the name in the author listing, as well as a corresponding footnote on the title page indicating “Current Address” listing the new affiliation.   Corrections to affiliations or contact information due to relocation after publication is not permitted.

 

INTERNAL REVIEW BOARD APPROVALS/WAIVERS

(as described and defined on the World Medical Association's website; www.wma.net)

When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

If the study is judged exempt from review, a statement from the committee is required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and in a sentence declaring adherence should be included in the Materials and Methods section of the manuscript.

ETHICS OF EXPERIMENTATION

All articles involving the use of human fetuses, fetal tissue, embryos, and embryonic cells must adhere to the US Public Law 103–41, effective December 13, 2001. (http://ethics.od.nih.gov/).

ETHICAL TREATMENT OF ANIMALS

All peer-reviewed submissions containing animal experiments must comply with local and national regulatory principles and contain a statement in the Materials and Methods section stating whether their national and institutional guidelines for the care and use of laboratory animals were followed.

For further information, consult the World Medical Association’s website: https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/

All submissions to PMR must contain:

AUTHOR DISCLOSURE STATEMENTS

  • Competing Interests. A competing interest exists when an individual (or the individual's institution) has financial or personal relationships that may inappropriately influence his actions. These competing interests may be potential or actual, financial or other.
  • Personal Financial Interests. Stocks or shares in a company that may gain or lose financially from publication of the article; consulting fees or other remuneration from an organization that may gain or lose financially from publication of the article; patents or patent applications that are owned by or licensed to companies/institutions that may gain or lose value from publication of the article.
  • Funding. Research support by organizations that may gain or lose financially from publication of the article. This support includes salary, equipment, supplies, honoraria, reimbursement or prepayment for attending symposia, and other expenses.
  • Employment. Recent (within the past 5 years), current, or anticipated employment by an organization that may gain or lose financially from publication of the article.
  • Other Competing Interests. Any personal relationship which may inappropriately affect the integrity of the research reported (by an author) or the objectivity of the review of the manuscript (by a reviewer or Editor), for example, competition between investigators, previous disagreements between investigators, or bias in professional judgment.

INTERNAL REVIEW BOARD APPROVAL(S) or WAIVER(S)

(as described and defined on the World Medical Association's website; www.wma.net)

When reporting research involving human data, authors should indicate whether the procedures followed have been assessed by the responsible review committee (institutional and national), or if no formal ethics committee is available, were in accordance with the Declaration of Helsinki as revised in 2013. If doubt exists whether the research was conducted in accordance with the Helsinki Declaration, the authors must explain the rationale for their approach and demonstrate that the institutional review body explicitly approved the doubtful aspects of the study. Approval by a responsible review committee does not preclude editors from forming their own judgment whether the conduct of the research was appropriate.

If the study is judged exempt from review, a statement from the committee is required. Informed consent by participants should always be secured. If not possible, an institutional review board must decide if this is ethically acceptable. This information should be outlined in the cover letter accompanying the submission, and in a sentence declaring adherence should be included in the Materials and Methods section of the manuscript.

OPEN ACCESS / CC-BY LICENSING

Palliative Medicine Reports is an Open Access peer-reviewed journal. Creative Commons CC-BY and CC-BY-NC licensing will be applied to all accepted articles.  The regular Article Processing Charge (APC) is waived for papers submitted prior to February 28, 2020.  Beginning on March 1, 2020, an APC of $1,250.00 USD will be instituted.

PERMISSIONS

When reproducing copyrighted material such as figures, tables, or excerpted text, the author(s) of the submitted paper must obtain permission from the original publisher and submit it concurrently with the manuscript. The publication from which the figure or table is taken must be listed in the reference list. Finally, a footnote to a reprinted table or the legend of a reprinted figure should read, "Reprinted by permission from Jones et al." and list the appropriate reference. All permissions must be supplied at the time of submission.  Authors are responsible for any fees that may be incurred by securing permission to reproduce or adapt material from other published sources.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany the proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher as reprints ordered after the issue is printed will be charged at a substantially higher rate.

REUSE OF MATERIAL POSTED ON SOCIAL MEDIA

As material posted on social media platforms is usually not peer-reviewed content, it is not permitted as an official citation and/or reference.

 

DATA SHARING

Palliative Medicine Reports strongly advocates the sharing and archiving of the data and any other artifacts that define and support the results stated in a manuscript in a suitable public repository (in accordance with valid privacy, legal, and ethical guidelines). A data availability statement should be included in the manuscript (in the Methods section or as a separate section at the end of the manuscript), describing the location of the data, with details on how it can be accessed as well as any licensing information. If the data is not publicly available or accessible, that information should also be provided.

Datasets should be cited in the reference list by Author (Year). Title. Publisher. Identifier/DOI.

Important: Please check with your funding agencies to ensure that are you following their data sharing polices. If your funding agency has additional requirements exceeding our policy, you must follow the requirements of your funder.

PREPRINT SERVERS

A preprint is a complete draft of a research paper that is shared on a public preprint server prior to submission to a journal for peer review.
 
Mary Ann Liebert, Inc., allows for papers that were previously deposited on preprint servers to be submitted to our journals, with the proviso that the author updates any preprint versions with a link to the final published article.  All submissions are subject to peer review and allowing the submission of preprint manuscripts does not guarantee publication in any Mary Ann Liebert, Inc., journal.
 
The submitting author of a paper that was previously deposited to a preprint server should include a disclosure on the title page of the manuscript indicating the name and website of the server and include the DOI number of the preprint.
 
Referencing/citing non-peer-reviewed material that is found on any preprint server is generally discouraged by Mary Ann Liebert, Inc., journals, but if it is necessary, the citation must make it clear that the content is not officially published in a journal, and can only be found on a preprint server.

 

 

RESEARCH FUNDER COMPLIANCE (FundRef)

Upon submission of a manuscript, the submitting agent will have an opportunity to enter funding/grant information. If funding information is entered correctly, the publisher will deposit the funding acknowledgements from the article as part of the standard metadata to FundRef. The entered information should include funder names, funder IDs (if available), and associated grant numbers.  Special care should be taken when entering this information to ensure total accuracy. (See https://www.crossref.org/services/funder-registry/ for a listing of more than 13,000 international funding agencies.)

GOVERNMENT FUNDED RESEARCH

Palliative Medicine Reports is fully NIH-, HHMI-, RCUK, and Wellcome Trust-compliant.

OPEN ACCESS

Our open access publishing solutions allow you to comply with the open access policies of your institution, government, and funding body. If you are employed or funded by the National Institute of Health (NIH), the Wellcome Trust, Research Councils UK (RCUK), or Howard Hughes Medical Institute (HHMI), you can find more information below:

  • NIH and HHMI Public Access Policy–In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final paginated version of the published article to PubMed Central (PMC) on behalf of the authors after a 12-month embargo period. Authors need not take any action. This service is provided free of charge. Authors who wish to remove the 12-month embargo period are encouraged to consider publishing with Open Option.
  • Wellcome Trust Policy–To easily comply, you can choose to have your article published open access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the Wellcome Trust.
  • Research Councils UK (RCUK)–To easily comply, you can choose to have your article published Open Access under the Creative Commons Attribution (CC BY) license. The publication charge will be covered by the RCUK.

 

ATTENTION: To ensure the receipt of all communications from the journal editorial office and publisher, please whitelist the following domains to prevent spam filter detection or non-deliverables:

  • manuscriptcentral.com
  • amazonses.com
  • liebertpub.com

Failure to whitelist these domains may significantly hinder the progress of peer review on submitted manuscripts, and the production process of accepted papers.

POST-ACCEPTANCE / PRODUCTION

All accepted manuscripts will go through copyediting, typesetting, figure sizing and placement, author proofing, corrections, revisions (from corrected proofs), online-ahead-of-print release, and lastly, issue assignment. Depending on the length and complexity of any accepted submission, these steps typically take 3-6 weeks from acceptance.  Changes or alterations to a submission are not permitted after acceptance, but should be addressed in page proofs.

PAGE PROOFS

Page proofs will be sent to the corresponding author as designated in Manuscript Central when the manuscript was submitted. It is the corresponding author's responsibility to share the page proofs with co-authors, if desired, and to coordinate all authors' corrections into one proof. The Publisher will not accept corrections from multiple authors/sources.

AUTHOR RESPONSE TO GALLEY PROOF

  • The corresponding author is responsible for returning corrected galley proofs generally within 72 hours of receipt.
  • If the corresponding author does not respond within that timeframe, the manuscript may be delayed in the publication schedule, or published as is, at the discretion of the Editor and Publisher.
  • If the corresponding author expects to be unavailable during the time the manuscript is in production, the publisher should be provided with an alternate contact. 
  • Only corrections directly related to errors in typesetting and/or layout will be allowed.
  • Any requested changes related to content, or that alter the outcome of a study, will require the approval of the Editor, and may require further peer review.

REPRINTS

Reprints may be ordered by following the special instructions that will accompany the proofs and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher as reprints ordered after the issue is printed will be charged at a substantially higher rate.

POST-PUBLICATION CORRECTIONS

In the event an error is discovered after publication of an article, the corresponding author should submit the correction in writing to the editorial office for consideration.  After editor approval, alterations will be made to the online version of the article, and if the errors are significant, an official correction statement will be issued.

  • Changes to author affiliations or contact details due to relocation after publication are not permitted.
  • Corrections to meeting abstracts will be made only to the online version.  The Journal does not issue formal correction statements for corrections to meeting abstracts, regardless of the nature of the correction.
  • Correction Statements/Errata to published articles that require the reproduction of color figure(s) and/or table(s) may incur additional costs to the author(s).

RETRACTIONS**

The journal and its publisher are committed to upholding the proper protocols and established standards of peer review.  Published papers found to be in violation of any of scientific misconduct, or in the accepted principles of peer review and scientific publishing, will be officially retracted from the literature.  An official retraction notice explaining in full detail the circumstances surrounding the need for a retraction.

**Any publication fees for retracted and/or withdrawn articles are nonrefundable in any circumstance.

Mary Ann Liebert, Inc., publishers permits the use of accepted pre-published manuscripts for the sole purpose of pitching to news organizations under strict embargo, and with the approval of and expressed collaboration with the publisher. A watermarked PDF version of the article (not a Word document or any other editable version) may be shared only with named, personal contacts at trusted news sources upon request. News sources must be informed upon delivery of the PDF that the manuscript is for reference-only purposes and can be used only in preparation of their news coverage of the article. It is strictly prohibited to publicly share, post, or otherwise distribute the PDF in any media format. Upon official publication of the article, news organizations must link directly to the published article on the publisher’s journal website. To coordinate publication timing and press efforts, please contact the Director of Marketing, Kathryn Ryan (kryan@liebertpub.com).

RESPONDING TO ALLEGATIONS OF POSSIBLE MISCONDUCT

The Publisher is committed to helping protect the integrity of the public scientific record by sharing reasonable concerns with authorities who are in the position to conduct an appropriate investigation into an allegation. As such, all allegations of misconduct will be referred to the Editor-In-Chief of the Journal who in turn will review the circumstances, possibly in consultation with associate editors and/or members of the editorial board, or other experts in the field. Initial fact-finding will usually include a request to all the involved parties to state their case and explain the circumstances in writing. In questions of research misconduct centering on methods or technical issues, the Editor-In-Chief may confidentially consult experts who are blinded to the identity of the individuals, or if the allegation is against an editor, an outside expert. The Editor-In-Chief will arrive at a conclusion as to whether there is enough reasonable evidence that the possibility of misconduct occurred.

When allegations concern authors, the peer review and/or publication process for the manuscript in question will cease while the process described herein is researched. The investigation will be taken to completion even if the authors withdraw their paper. In the case of allegations against reviewers or editors, they will be replaced in the review process while the matter is investigated.

Editors or reviewers who are found to have engaged in scientific misconduct will be removed from further association with the Journal, and reported to their institution.

If an inquiry concludes there is a reasonable possibility of misconduct, the Editor-in-Chief will retract the paper from the Journal and the scientific record. If the paper is still under peer review, the Editor-in-Chief will withdraw the paper from consideration to the Journal.

All effort will be made to keep all allegations confidential.

DEFINITIONS OF SCIENTIFIC MISCONDUCT

Mary Ann Liebert, Inc., publishers follows the guidelines and rules regarding scientific misconduct put forth by the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the Office of Research Integrity (ORI).

Scientific misconduct and violation of publishing ethics vary and can be intentionally or unintentionally perpetrated. Some examples of misconduct and violations include, but are not limited to, the following:

  • Scientific Misconduct: Fabrication, falsification, concealment, deceptive reporting, or misrepresentation of any data constitutes misconduct and/or fraud.
  • Authorship Disputes: Deliberate misrepresentation of a scientist's contribution to the published work, or purposefully omitting the contributions of a scientist.
  • Misappropriation of the ideas of others: Improper use of scholarly exchange and activity may constitute fraud. Wholesale appropriation of such material constitutes misconduct.
  • Violation of generally accepted research practices: Serious deviation from accepted practices in proposing or carrying out research, improper manipulation of experiments to obtain biased results, deceptive statistical or analytical manipulations, or improper reporting of results constitutes misconduct and/or fraud.
  • Material failure to comply with legislative and regulatory requirements affecting research: Including but not limited to serious or substantial, repeated, willful violations of applicable local regulations and law involving the use of funds, care of animals, human subjects, investigational drugs, recombinant products, new devices, or radioactive, biologic, or chemical materials constitutes misconduct.
  • Conflict of Interest: Nondisclosure of any conflicts, direct or indirect, to the Journal which prevents you from being unbiased constitutes misconduct.
  • Deliberate misrepresentation: of qualifications, experience, or research accomplishments to advance the research program, to obtain external funding, or for other professional advancement constitutes misconduct and/or fraud.
  • Plagiarism: Purposely claiming another's work or idea as your own constitutes misconduct and/or fraud.
  • Simultaneous Submission: Submitting a paper to more than one publication at the same time constitutes misconduct.

RETRACTIONS

The Journal and its publisher are committed to upholding the proper protocols and established standards of peer review.  Published papers found to be in violation of any of scientific misconduct, or in the accepted principles of peer review and scientific publishing, will be officially retracted from the literature.  An official retraction notice explaining in full detail the circumstances surrounding the need for a retraction.

Palliative Medicine Reports is an Open Access peer-reviewed journal. Creative Commons CC-BY and CC-BY-NC licensing will be applied to all accepted articles.  The regular Article Processing Charge (APC) is $1,250.00 USD.

Mary Ann Liebert, Inc., deposits and archives all publications in Portico for long-term digital preservation. Your article will be easily searchable on Google, Google Scholar, and other search engines.

The Office of Foreign Assets Control (OFAC) of the US Department of the Treasury administers and enforces economic and trade sanctions based on US foreign policy and national security goals against targeted foreign countries and regimes, terrorists, international narcotics traffickers, those engaged in activities related to the proliferation of weapons of mass destruction, and other threats to the national security, foreign policy or economy of the United States. (Source: https://www.treasury.gov/about/organizational-structure/offices/pages/office-of-foreign-assets-control.aspx)

Our journal editors welcome contributions from researchers around the world; however, they are also required to follow sanction laws and regulations. Upon the date of this update (August 2020), sanction measures imposed by the United States, United Nations, European Union, and Australia are currently in place against the following countries: Cuba, Crimea, Iran, North Korea, and Syria. Journal editors will treat with caution any submission from a sanctioned country regarding the subject matter and will seek appropriate legal advice from the publisher if necessary.

Papers from sanctioned countries that are submitted to any Mary Ann Liebert, Inc., journal MUST contain a confirmation statement after the conclusion section of the manuscript which indicates that EACH listed author confirms that their research is supported by an institution that is primarily involved in education or research.

For further questions, please contact our Director of Production and Editorial Operations.

Palliative Medicine Reports is owned and published by Mary Ann Liebert, Inc., publishers, 140 Huguenot Street, 3rd Floor, New Rochelle, NY 10801; Tel: 914-740-2100; Email: Info@liebertpub.com; Website: www.liebertpub.com/PMR

The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.